CNR Institutional Research Information System

DE FRANCISCIS, VITTORIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.457
NA - Nord America 803
EU - Europa 369
SA - Sud America 356
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.029
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 755
SG - Singapore 650
CN - Cina 300
BR - Brasile 294
VN - Vietnam 167
HK - Hong Kong 153
IT - Italia 120
FR - Francia 87
KR - Corea 57
NL - Olanda 53
JP - Giappone 30
AR - Argentina 24
DE - Germania 23
CA - Canada 22
IN - India 22
MX - Messico 18
GB - Regno Unito 17
BD - Bangladesh 15
FI - Finlandia 13
ZA - Sudafrica 13
EC - Ecuador 11
IL - Israele 10
CO - Colombia 8
IQ - Iraq 7
MA - Marocco 7
TR - Turchia 7
AT - Austria 6
PY - Paraguay 6
UZ - Uzbekistan 6
VE - Venezuela 6
EG - Egitto 5
HU - Ungheria 5
ID - Indonesia 5
RU - Federazione Russa 5
AL - Albania 4
ES - Italia 4
GR - Grecia 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
IE - Irlanda 3
PH - Filippine 3
PL - Polonia 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
UA - Ucraina 3
UY - Uruguay 3
DZ - Algeria 2
KE - Kenya 2
LT - Lituania 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
RO - Romania 2
RS - Serbia 2
SE - Svezia 2
SI - Slovenia 2
SN - Senegal 2
TN - Tunisia 2
TW - Taiwan 2
AU - Australia 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CD - Congo 1
CG - Congo 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
GT - Guatemala 1
IR - Iran 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LY - Libia 1
ME - Montenegro 1
NI - Nicaragua 1
NO - Norvegia 1
PS - Palestinian Territory 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
ZM - Zambia 1
Totale 3.029
Salva come PNG Salva come JPEG
Città #
Singapore 406
Santa Clara 250
Hong Kong 151
Hefei 107
San Jose 75
Lauterbourg 73
Beijing 70
Ho Chi Minh City 63
Seoul 56
Ashburn 54
Los Angeles 48
Hanoi 36
São Paulo 34
New York 22
Milan 21
Tokyo 20
Naples 15
Marigliano 13
Da Nang 11
Dallas 11
Frankfurt am Main 11
Curitiba 10
Buffalo 9
Rio de Janeiro 9
Atlanta 8
Helsinki 8
Montreal 8
Brasília 7
Minamishinagawa 7
Bengaluru 6
Figino 6
Johannesburg 6
London 6
Orem 6
Tashkent 6
Ascoli Piceno 5
Dhaka 5
Guayaquil 5
Houston 5
Hải Dương 5
Quito 5
Amsterdam 4
Baghdad 4
Belo Horizonte 4
Bogotá 4
Budapest 4
Casandrino 4
Chicago 4
Düsseldorf 4
Giugliano in Campania 4
Guarulhos 4
Lappeenranta 4
Miami 4
New London 4
Orlando 4
Palermo 4
Philadelphia 4
Phoenix 4
Asunción 3
Biên Hòa 3
Cairo 3
Campinas 3
Campos dos Goytacazes 3
Cape Town 3
Caruaru 3
Casablanca 3
Chennai 3
Dublin 3
Genoa 3
Louisville 3
Manaus 3
Phủ Lý 3
Plano 3
Porto Alegre 3
Rosario 3
Salvador 3
Sorocaba 3
São Gonçalo 3
The Bronx 3
Vũng Tàu 3
Alegrete 2
Alfenas 2
Almirante Tamandaré 2
Aracaju 2
Athens 2
Baku 2
Baltimore 2
Barretos 2
Berlin 2
Boydton 2
Burnsville 2
Byron 2
Caracas 2
Catanduva 2
Chaguanas 2
Ciudad del Este 2
Cleveland 2
College Station 2
Columbiana 2
Council Bluffs 2
Totale 1.853
Salva come PNG Salva come JPEG
Nome #
Identification of a novel RNA aptamer that selectively targets breast cancer exosomes 97
Targeted systematic evolution of an RNA platform neutralizing DNMT1 function and controlling DNA methylation 79
Direct determination of small RNAs using a biotinylated polythiophene impedimetric genosensor 76
Selection of a nuclease‐resistant rna aptamer targeting cd19 73
Multifunctional Aptamer-miRNA Conjugates for Targeted Cancer Therapy 70
Diagnostic and Therapeutic Aptamers A Promising Pathway to Improved Cardiovascular Disease Management 62
Aptamer-based RNA-bio-drugs for the combined therapy of GBM 61
Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFR beta Aptamer 59
Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression 57
A Theranostic "SMART" Aptamer for Targeted Therapy of Prostate Cancer. 55
An Anti-BCMA RNA Aptamer for miRNA Intracellular Delivery 55
A regulatory mechanism involving TBP-1/Tat-Binding Protein 1 and Akt/PKB in the control of cell proliferation. 53
STAT3 targeting by an aptamer-based conjugate for glioblastoma multiforme therapy 52
The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells 52
Nucleic acid aptamers targeting epigenetic regulators: An innovative therapeutic option 50
GDNF selectively induces microglial activation and neuronal survival in CA1/CA3 hippocampal regions exposed to NMDA insult through Ret/ERK signalling. 49
Affinity immobilization of aptamers on graphene oxide for biosensor applications 49
Combined Targeting of Glioblastoma Stem-Like Cells by Neutralizing RNA-Bio-Drugs for STAT3 48
Identification of an interfering ligand aptamer for EphB2/3 receptors 46
Signaling through Ras Is Essential for ret Oncogene-induced Cell Differentiation in PC12 Cells 45
Nucleic acids delivering nucleic acids 45
Engineering Aptamers for Biomedical Applications: Part II 44
Targeting breast cancer exosomes with nucleic aptamers: Innovative tools for early diagnosis and therapy 44
RET/PTC activation in human thyroid carcinomas 44
Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells 43
Aptamer chimeras for therapeutic delivery: The challenging perspectives 43
The isolectin IB4 binds RET receptor tyrosine kinase in microglia. 41
A Neutralizing RNA Aptamer against EGFR Causes Selective Apoptotic Cell Death 41
Selective delivery of therapeutic single strand antimiRs by aptamer-based conjugates 40
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma 40
A trans-disciplinary approach to cancer research 37
Distribution and bioactivity of the Ret-specific D4 aptamer in three-dimensional collagen gel cultures. 35
Use of yeast artificial chromosomes to study the genomic organization of human dbl proto-oncogene. 34
Aptamers in Bordeaux, 24-25 June 2016 34
Abrogation of Nerve Growth Factor-induced Terminal Differentiation by ret Oncogene Involves Perturbation of Nuclear Translocation of ERK 34
Targeting Insulin Receptor with a Novel Internalizing Aptamer. 34
miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis 33
The recent blooming of therapeutic aptamers 33
A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells 32
Nucleic acid aptamers for in vivo molecular imaging 32
The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype. 32
Aptamer-miRNA conjugates for cancer cell-targeted delivery 32
Expression of GFRalpha1 receptor splicing variants with different biochemical properties is modulated during kidney development . 32
Noncoding RNAs in Cancer Medicine. 31
Coupling aptamers to short interfering RNAs as therapeutics 31
Cell-specific aptamers for targeted therapies. 31
cleic acids in human glioma treatment: innovative approaches and recent results 30
Aptamers are an innovative and promising tool for phytoplankton taxonomy and biodiversity research 30
Challenging cancer targets for aptamer delivery. 30
Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFR? Aptamer. 30
Thyrotropin stimulates transcription from the ferritin heavy chain promoter 29
A Trojan horse for human immunodeficiency virus 29
Aptamer-mediated targeted delivery of therapeutics: An update 29
Differential SELEX in human glioma cell lines. 29
Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models 29
Arresting the colonial destiny of metastatic seeds with DNA aptamers. 28
Shp2 in PC12 cells: NGF versus EGF 28
A cross-talk between TrkB and Ret tyrosine kinases receptors mediates neuroblastoma cells differentiation. 28
New insight into clinical development of nucleic acid aptamers. 28
Recent advance in biosensors for microRNAs detection in cancer 28
SERS-active metal-dielectric nanostructures integrated in microfluidic devices for label-free quantitative detection of miRNA 28
Expression of the RET oncogene induces differentiation of SK-N-BE neuroblastoma cells 27
Direct interactions among the tyrosine kinase receptor Ret, the GDNF and the GFR±1 molecules. 27
Smooth muscle cell-targeted RNA aptamer inhibits neointimal formation 27
5'-End ret splicing: absence of variants in normal tissues and intron retention in pheochromocytomas. 27
Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL 26
ANALYSIS AND SEQUENCING OF THE GENOMIC DNA REGION SPANNING THE HUMAN DBL PROTOONCOGENE 26
TSH regulation of ferritin H chain messenger RNA levels in the rat thyroids 26
Targeting cancer cells with nucleic acid aptamers 26
Aptamer-Based Technologies as New Tools for Proteomics in Diagnosis and Therapy Frontiers in Drug Design & Discovery 25
Developing aptamers by cell-based SELEX 25
Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase 25
An Autocrine Loop Involving Ret and Glial Cell-Derived Neurotrophic Factor Mediates Retinoic Acid-Induced Neuroblastoma Cell Differentiation 24
Aptamer-mediated selective delivery of short RNA therapeutics in cancer cells 24
Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2-terminal protein kinases (JNKs): Evidence for a divergence of the ERKs and JNKs pathways induced by Ret 24
Human dbl proto-oncogene in 85 kb of Xq26, and determination of the transcription initiation site. 23
In vitro selection of RNA aptamers against CA125 tumor marker in ovarian cancer and its study by optical biosensing 23
Activated RET/PTC oncogene elicits immediate early and delayed response genes in PC12 cells 21
Ligand stimulation of a RET chimeric receptor carrying the activating mutation responsible for the multiple endocrine neoplasia type 2B 20
Changes in cellular gene expression in rat thyroid epithelial cells transformed by the Kirsten Murine Sarcoma Virus 20
Human dbl proto-oncogene in 85 kb of Xq26, and determination of the transcription initiation site 20
Elevated Expression of the Tyrosine Phosphatase SHP-1 Defines a Subset of High-Grade Breast Tumors 19
The chimeric aptamer axl-miR-214sponge inhibits breast cancer and melanoma dissemination 18
Nucleic Acid-Based Aptamers As Promising Therapeutics In Neoplastic Diseases 17
Totale 3.113
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.067
article - articoli 10.243
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 535
Totale 21.845
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202432 0 0 0 0 0 0 0 0 1 0 20 11
2024/20251.148 8 4 95 40 213 48 51 51 39 73 266 260
2025/20261.812 75 170 213 317 291 86 257 102 79 119 64 39
2026/2027121 121 0 0 0 0 0 0 0 0 0 0 0
Totale 3.113